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contact: Corinne Gaffet, LCE Agency, 3, rue Maitre AMERICAN BOARD OF INTERNAL MEDICINE
Albert, 75005 Paris, France. Telephone: 33 1 55 42 The American Board of Internal Medicine announces
80 77 or 76; Fax: 33 1 55 42 80 79; E-mail: c.gaffet@ the dates of the Board’s 2002 Examinations. The registra-
wanadoo.fr tion period for the 2002 Certification Examination in
The First International Course on Hemodialysis Tech- Nephrology is January 1, 2002, to April 1, 2002. The late
registration period is from April 2, 2002, to June 1, 2002.nology will be held June 19–22, 2002, in Vicenza, Italy.
The date of the examination is November 6, 2002. It isThe Vicenza International Courses are a well-established
important to note that the Board now offers all subspeci-forum for the disucssion of scientific advances, including
alty certification examinations annually. For further in-peritoneal dialysis and intensive care nephrology. Held
formation and application forms, contact: Registrationevery three years, this course on hemodialysis technology
Section, American Board of Internal Medicine, 510 Wal-is being organized in collaboration with the departments
nut Street, Suite 1700, Philadelphia, PA 19106-3699.of nephrology of Bergamo and Torino as an annual meet-
Telephone: 1-800-441-2246 or 1-215-446-3500; Fax: 1-215-ing of the Inter-Institutional Department of Renal Dis-
446-3590; E-mail: request@abim.org; Web site: http://www.
eases. For further information, contact: Professor Clau-
abim.org
dio Ronco, Co-Chairman of the Course. Telephone: (39)
0444-993650 or 993869; Fax: (39) 0444-993949; E-mail:
ERRATAinfo@vicenzanephrocourses.com; Web site: http:/www.
vicenzanephrocourse.com Adler SG, Kang SW, Feld S, et al: Glomerular
mRNAs in human type 1 diabetes: Biochemical evidenceThe 19th Scientific Meeting of the International Society
for microalbuminuria as a manifestation of diabetic ne-of Hypertension and the 12th European Meeting on Hy-
phropathy. Kidney Int 60:2330–2336, 2001pertension will be held June 23–27, 2002, in Prague,
Czech Republic. For further information, contact: Con-
In the above-cited article, on page 2333, the legendgress Secretariat. Telephone: 004202 8400 1477 or 004202
for Figure 1 should read as follows:8400 1444; Fax: 004202 8400 1448; E-mail: hypertension
2002@guarant.cz; Web site: www.hypertension2002.cz. A
satellite symposium on renal hypertension will be held
Sunday, June 23, 2002, in Liberec, Czech Republic. For
further information, contact: Prof. Vladimir Tesar, Divi-
sion of Nephrology, 1st Department of Medicine, Charles
University, U nemocnice 2, Prague 2, Czech Republic.
Telephone/fax: 004202 24962696; E-mail: tesarv@beba.
cesnet.cz
The 20th Annual Meeting of the International Society
of Blood Purification, ISBP, will be held September 5–7,
2002, in Celle, Germany. The deadline for abstract sub-
mission is June 1, 2002. For further information, contact:
ISBP 2002 c/o Congress Union Celle, Thaerplaz 1,
D-29221 Celle, Germany. Telephone: 49 51141 9193;
Fax: 49 5141 919 444; E-mail: info@ISBP2002.com;
Web site: http://www.ISBP2002.com
The Fifth International Congress on Mechanisms of
Fig. 1. Glomerular collagen2(IV) and connective tissue growth factorUremic Toxicity will be held September 13–16, 2002, at
(CTGF) mRNA levels are nearly identical in microalbuminuric (MA;the University Church, Wu¨rzburg, Germany. The meet- ) and overtly proteinuric subjects ( ) and higher than in living renal
donors (LRD:) and normoalbuminuric subjects (NA; ). Glomerularing will feature current information on uremia and the
GAPDH mRNA levels were not significantly different. *P  0.03 andcardiovascular system. The deadline for abstract submis-
**P  0.01 vs. LRD and NA.
sion is April 22, 2002. The complete program listing
is available at http://www.uni.wuerzburg.de/nephrologie. The author and editor apologize for the error.
For further information, contact: Professor Christoph
Wanner, Department of Medicine, Division of Nephrol- Koul S, Chaturvedi LS, Sekhon A, et al: Effects of
ogy, University of Wu¨rzburg, Josef-Schneider Str. 2, oxalate on the re-initiation of DNA synthesis in LLC-
D-97080 Wu¨rzburg, Germany. Fax: 49 932 201 3502; PK1 cells do not involve p42/44 MAP kinase activation.
Kidney Int 61:525–533, 2002E-mail: c.wanner@medizin.uni-wuerzburg.de
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In the above-cited article on page 525, the first sen- 216 South Kingshighway
St. Louis, Missouri 63110-1092, USAtence of the Results section of the Abstract should read
as follows:
For manuscripts prior to acceptance, please contact:
Mrs. Patricia Morrissey
Exposure of growth arrested LLC-PK1 cells to oxalate
Via telephone: 314-454-8919
resulted in the re-initiation of the DNA synthesis that
Via facsimile: 314-454-8907
was abolished by pretreatment with transcription/
Via E-mail: pmorriss@im.wustl.edu
translation inhibitors.
Mrs. Karen Westrich
Via telephone: 314-454-8898The authors apologize for the error.
Via facsimile: 314-454-8907
Via E-mail: kwestrich@im.wustl.edu
FOR SUBMISSION OF MANUSCRIPTS
For manuscripts after acceptance, please contact:AND ANNOUNCEMENTS
Ms. Shellie T. Newell
Manuscripts must be submitted online to the Kidney
Via telephone: 314-4454-8916
International Website (http://ki.manuscriptcentral.com). All
Via facsimile: 314-454-8907
related editorial correspondence should be submitted to:
Via E-mail: snewell@im.wustl.edu
Saulo Klahr, M.D.
Editor, Kidney International Mrs. Katherine Spakowski
Via telephone: 314-454-7016Washington University School of Medicine
at Barnes-Jewish Hospital (North Campus) Via facsimile: 314-454-8907
Via E-mail: kspakows@im.wustl.eduDepartment of Medicine, Suite 4300
